Home / Knowledge Center /

Almac validate Illumina TruSight® Tumor 170 Assay

*By submitting your information you acknowledge that you have read the privacy statement and you consent to our processing the data in accordance with that privacy statement. We may, from time to time, send you material relevant to your interests. If you change your mind at any time about wishing to receive material from us, you can send an email to [email protected]. Every email we send you will also include an unsubscribe link so you can unsubscribe from our marketing list.

In this webinar, Dr Leeona Galligan, VP UK Operations at Almac Diagnostic Services will discuss:

  • An overview on Almac Diagnostic Services
  • TruSight® Tumor 170 overview
  • TruSight® Tumor 170 Analytical Validation at Almac
  • Clinical Trial Framework for TruSight® Tumor 170 at Almac

For more information visit our Current Assay section.

View Resource
Almac Logo

Diagnostic Services

Your global partner for biomarker discovery, development & commercialization.

Genomic Services

We offer a range of genomics platform and chemistry options, alongside expert data sciences support and a full sample management service.

Clinical Trial Assays

Comprehensive development, validation & delivery service for research and clinical use assays from our global clinical laboratories in USA, Europe and APAC.

Companion Diagnostics

A collaborative Companion Diagnostic partnership approach with a deep understanding of client needs. We offer CDx development, manufacture & commercialization services.

Learn More

Please complete this form to view the Webinar

This website uses cookies. By continuing to browse the site, you are agreeing to our use of cookies